Patent classifications
C07C251/86
USE OF SMALL MOLECULE INHIBITORS TO KLF10 FOR MODULATION OF T REGULATORY CELLS AND CANCER IMMUNOTHERAPY
The invention relates to compositions and methods for inhibiting Krüppel-like Factor 10 (KLF10) for modulation of T regulatory cells and cancer immunotherapy.
USE OF SMALL MOLECULE INHIBITORS TO KLF10 FOR MODULATION OF T REGULATORY CELLS AND CANCER IMMUNOTHERAPY
The invention relates to compositions and methods for inhibiting Krüppel-like Factor 10 (KLF10) for modulation of T regulatory cells and cancer immunotherapy.
Organ preconditioning formulation with mitochondrial elongating agents
Provided herein is a formulation to pre-treat an organ prior to transplantation and for inducing mitochondrial morphological alterations.
Organ preconditioning formulation with mitochondrial elongating agents
Provided herein is a formulation to pre-treat an organ prior to transplantation and for inducing mitochondrial morphological alterations.
ADDITIVE FOR MEDIUM FOR PROMOTING PRODUCTION OF PARACRINE FACTOR
The present invention provides a medium additive for promoting production of a paracrine factor in a cell, containing a compound represented by the following formula (I) or a salt thereof:
##STR00001##
wherein each symbol is as defined in the DESCRIPTION.
ADDITIVE FOR MEDIUM FOR PROMOTING PRODUCTION OF PARACRINE FACTOR
The present invention provides a medium additive for promoting production of a paracrine factor in a cell, containing a compound represented by the following formula (I) or a salt thereof:
##STR00001##
wherein each symbol is as defined in the DESCRIPTION.
Analogs of Nitrofuran Antibiotics to Combat Resistance
Novel compounds and methods of killing or inhibiting the growth of bacteria.
Analogs of Nitrofuran Antibiotics to Combat Resistance
Novel compounds and methods of killing or inhibiting the growth of bacteria.
PARG INHIBITORS AND METHOD OF USE THEREOF
Provided herein are, inter alia, compounds inhibiting poly(ADP-ribose) Glycohydrolase (PARG) in a cancer cell and methods of treating cancer using compounds of the invention.
PARG INHIBITORS AND METHOD OF USE THEREOF
Provided herein are, inter alia, compounds inhibiting poly(ADP-ribose) Glycohydrolase (PARG) in a cancer cell and methods of treating cancer using compounds of the invention.